Incredible to see how AI is transforming care in real time. StateViewer is just one example innovation at Mayo Clinic. newsnetwork.mayoclinic.org/discussion/how… mayocl.in/4likX6L

In this test-specific episode of the "Answers From the Lab" podcast, John Lieske, M.D., and Sandra Taler, M.D., explain how our new assay can help clinicians evaluate individuals with resistant hypertension to meet blood pressure goals. bit.ly/4keT8eb

Built on a whole-exome backbone with reflex capabilities, a new genetic test developed at @MayoClinicLabs is redefining how clinicians diagnose and manage hereditary pancreatitis, offering clarity and a platform for future genomic innovation. bit.ly/4lrki2C

Mayo Clinic Laboratories (MCL) is a diagnostic company and reference laboratory that offers a catalog of 4,400 tests and pathology services. That number continues to climb as MCL relentlessly innovates on behalf of patients. mayocl.in/3I6m1Mo

Join our discussion with leaders from Digital Medicine Society, Kaiser Permanente, Mayo Clinic, and Vanderbilt University Medical Center examining the data infrastructure, evaluation pathways, and outcome metrics required for responsible scale. bit.ly/4ePYWtB

Mayo Clinic researchers link CAR-T cell aging to cancer relapse. newsnetwork.mayoclinic.org/discussion/may… mayocl.in/3GPMVb4

Leczcore Hainan Mellsser Hospital, a member of the Leczcore Group, have announced they are the newest member of the Mayo Clinic Care Network. newsnetwork.mayoclinic.org/discussion/lec… mayocl.in/3TUbdUe

“Anyone who has had repeat bouts of #pancreatitis of unknown etiology would benefit from this testing because it’s so valuable to be able to rule hereditary pancreatitis in or out,” says Linda Hasadsri, M.D., Ph.D. Listen to this podcast to learn more. bit.ly/46nJBhO

60%–80% of patients who experience a kidney stone event will have recurrent episodes later in life. @MayoClinicLabs' comprehensive urinary stone services enable accurate interpretation to guide clinical decisions. bit.ly/4o9QA47

After mysterious neurological symptoms began in 2010, Brad Karon, M.D., Ph.D., was diagnosed with paraneoplastic syndrome, a rare condition that led to groundbreaking research and test development at Mayo Clinic. Read his story. bit.ly/3UAUXYw

Advanced testing empowers physicians and healthcare providers with the right tools to confidently diagnose and treat some of the most complex hematologic malignancies. Download @MayoClinicLabs reference guide to browse the full suite of tests. bit.ly/45aBx2S

Summer is peak tick season. Listen to @parasitegal and Elitza Theel, Ph.D., discuss this year’s tick season and testing for tick-borne and mosquito-borne diseases. bit.ly/47qPCdT

How amazing! Mayo Clinic research is heading to space!🚀 newsnetwork.mayoclinic.org/discussion/may… mayocl.in/4lSXrgd

The robust portfolio of therapeutic testing provided by @MayoClinicLabs is an end-to-end testing approach that supports data-driven treatment decisions for your patients. Discover the difference. bit.ly/4262SBb

In this episode of “Answers From the Lab,” @parasitegal - chair of the Division of Clinical Microbiology at Mayo Clinic - and Bill Morice, MD, PhD - CEO and president of Mayo Clinic Laboratories - discuss recent news about the use of #AI tools in healthcare. bit.ly/4n3oSop

Check out @MayoClinicLabs’ microlearning on testing for #vectorbornedisease, which includes an overview of our algorithmic testing approach and co-infection testing. bit.ly/4n5NVr5

What’s expected—and what’s not—in #ACHD imaging? Benjamin W Eidem contributes to a case-rich American Society of Echocardiography #ASE2025 session full of diagnostic insights.

Happy Victory Monday!

In this episode of “Answers From the Lab,” @parasitegal, chair of the Division of Clinical Microbiology, and @drmattbinnicker, virologist and chief scientific officer of @MayoClinicLabs, discuss developments in viral infections. bit.ly/41LEtAZ

Join Andrew Harper, partner at Goodwin, for a session hosted by the Berg Innovation Exchange on the fundamentals of company formation. Learn how to choose the right entity, protect IP, structure equity and prepare for investment. Register to join us here: bit.ly/4nOx4sU